incretin hormone glp-1 Targeting both receptors together for a new generation of diabetes therapies A Tale of Two Incretins

Carbas, C

Both medications are given as a once-weekly subcutaneous injection and share similar pharmacokinetic characteristics, such as absorption, distribution, metabolism, and excretion

Concurrent evaluation of both peptides allows researchers to examine how cAMP-driven and calcium-dependent signaling pathways operate simultaneously within pituitary somatotrophs, providing a controlled model for studying pathway integration, receptor cross-communication, and endocrine signal coordination

She works closely with men and women of all ages to determine the best treatment method for their individual needs

Americas Poison Centers reported a nearly 1,500% increase in calls related to GLP-1s since 2019